- Home
- » Tags
- » Multicenter trial
Top View
- Drug Treatments for Covid-19: Living Systematic Review and Network BMJ: First Published As 10.1136/Bmj.M2980 on 30 July 2020
- Clinical Trial Protocol TITLE PAGE
- Prevalence of Celiac Disease: a Multicenter Trial in Pediatric Population from Five Urban Districts of Argentina
- The National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Network Randomized Clinical Trial in P
- DSMB Training Manual
- Mechanisms of Virulence and Resistance Nicola C
- Gul* Dance for Industry Using a Centralized IRB Review Process in Multicenter Clinical Trials
- Guidance for Industry: E9: Statistical Principles for Clinical Trials
- Azithromycin to Prevent Pseudomonas Aeruginosa Ventilator-Associated Pneumonia by Inhibition of Quorum Sensing: a Randomized Controlled Trial
- I01 Invited Session1
- Developing an Appropriate Data and Safety Monitoring Plan
- Support for Multicenter Clinical Trials Freeing up Clinician Investigators to Focus on The
- Improved Diagnostic Prediction of the Pathogenicity of Bloodstream
- Guideline for a Coordinated GCP-Monitoring of Clinical Trials in the Nordic Countries
- Variation Among Institutional Review Boards in Evaluating the Design of a Multicenter Randomized Trial
- Clinical Review of Investigational New Drug Applications
- Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance
- Providing Clinical Evidence of Effectiveness for Human And
- Data and Safety Monitoring Boards: the Downside
- Determining Adequate Sample Sizes
- Predicting Disease Progression in Progressive Supranuclear Palsy in Multicenter Clinical Trials
- How to Use a Subgroup Analysis Users' Guides to the Medical Literature Clinical Review & Education
- The Risk of Bloodstream Infection in Adults with Different Intravascular Devices: a Systematic Review of 200 Published Prospective Studies
- Problematic Variation in Local Institutional Review of a Multicenter Genetic Epidemiology Study
- Vanderbilt Shepherd Center for Healthcare Epidemiology and Antimicrobial Stewardship Research
- "Front Matter". In: Data Monitoring Committees in Clinical Trials
- COVID-19: Why SOLIDARITY and Discovery Trials May Fail to Bring Informative and Timely Results
- 16.1 Study Information
- Disclosures Multi-Center Trials
- DSMB Training Manual
- Data Monitoring Committees
- Study Protocol, Statistical Analysis Plan, And
- Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews
- Official Protocol Title: a Phase III Multicenter, Double-Blind
- A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of Mitogel™ (UGN-101) on Ablation of Upper Urinary Tract Urothelial Carcinoma
- COVID-19 Drug Therapy Tim Smith, Pharmd, BCPS; Jennifer Bushek, Pharmd; Aimée Leclaire, Pharmd, BCPS; Tony Prosser, Pharmd
- Study Protocol
- ICTR COVID-19 Clinical Research Center Town Hall Wednesday December 9, 2020 Town Hall Agenda